Abstract:Historically, there has been a scarcity of evidence-based topical therapy to hasten the healing of diabetic foot ulcers. But recently new evidence-based treatments have emerged from multicentre, randomised, controlled trials. This article highlights those trials, and describes the current pharmacological management of the diabetic foot ulcer and the advances that have been made in wound therapy to date. It provides an overview of topical and systemic pharmacotherapies in current use and those in development for future use in managing the diabetic foot. For each treatment, proposed mechanisms of action and evidence available to support their clinical use are presented. There is supporting randomised, controlled evidence for sucrose octasulfate in the treatment of neuro-ischaemic ulcers, and multi-layered patch of autologous leucocytes, platelets and fibrin in ulcers with or without ischaemia. There is also evidence for placentally derived products and for topical and systemic oxygen therapy in the healing of diabetic foot ulcers. Growth factors, bio-engineered tissues, stem cell therapy, gene therapy and peptide therapy also have some supporting evidence in the healing of diabetic foot ulcers. Nonsurgical debriding agents may be useful when the optimum approach of sharp debridement is not possible, and immunomodulators may be helpful for their antimicrobial effects, but robust data is still required to strengthen the case for general use. The review does not cover antimicrobials as their primary role are as anti-infectives and not in wound healing. The development of nanotechnology has created a means of prolonging the bioavailability of target molecules at the wound site, with the use of glass/hydrogel nanoparticles, polyethylene glycol and hyaluronic acid. Looking forward, novel therapies, including traction force-activated payloads, local delivery of short-interfering RNA and finally hydrogels incorporating bioactive agents or cells may provide possibilities for pharmacotherapy in the future.

Pharmaceutical perspectives of impaired wound healing in diabetic foot ulcer

Molecular immunological mechanisms of impaired wound healing in diabetic foot ulcers (DFU), current therapeutic strategies and future directions

Diabetic foot ulcer: Challenges and future

Physiological and Pathophysiological Aspects of Diabetic Foot Ulcer and its Treatment Strategies

Materials and Cytokines in the Healing of Diabetic Foot Ulcers

An Overview of Recent Clinical Trials for Diabetic Foot Ulcer Therapies

Experimental treatments in clinical trials for diabetic foot ulcers: wound healers in the pipeline

Recent Advances in Polymer-based Wound Dressings for the Treatment of Diabetic Foot Ulcer: An Overview of State-of-the-art

Stem Cell-Based Tissue Engineering Approaches for Diabetic Foot Ulcer: a Review from Mechanism to Clinical Trial

Diverse Antibacterial Treatments beyond Antibiotics for Diabetic Foot Ulcer Therapy

Recent advances on the development of wound dressings for diabetic foot ulcer treatment—A review

State‐of‐the‐Art and Future Challenges of Smart Wound Dressings for Diabetic Foot Ulcer Treatment

Recent advances in the adjunctive management of diabetic foot ulcer: Focus on noninvasive technologies

Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing

On diabetic foot ulcer knowledge gaps, innovation, evaluation, prediction markers, and clinical needs

Emerging Antimicrobial and Immunomodulatory Fiber-Based Scaffolding Systems for Treating Diabetic Foot Ulcers

Research advances in hydrogel-based wound dressings for diabetic foot ulcer treatment: a review

Understanding and treating diabetic foot ulcers: Insights into the role of cutaneous microbiota and innovative therapies

Injectable carrier hydrogel for diabetic foot ulcer wound repair

Insights of biopolymeric blended formulations for diabetic wound healing

Nanotechnology invigorated drug delivery and tissue engineering strategies for the management of diabetic foot ulcers: Therapeutic approaches and clinical applications